Cargando…
Cyclic AMP Signaling in Biliary Proliferation: A Possible Target for Cholangiocarcinoma Treatment?
Cholangiocarcinoma is a lethal disease with scarce response to current systemic therapy. The rare occurrence and large heterogeneity of this cancer, together with poor knowledge of its molecular mechanisms, are elements contributing to the difficulties in finding an appropriate cure. Cholangiocytes...
Autores principales: | Baiocchi, Leonardo, Lenci, Ilaria, Milana, Martina, Kennedy, Lindsey, Sato, Keisaku, Zhang, Wenjun, Ekser, Burcin, Ceci, Ludovica, Meadows, Vik, Glaser, Shannon, Alpini, Gianfranco, Francis, Heather |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8303798/ https://www.ncbi.nlm.nih.gov/pubmed/34359861 http://dx.doi.org/10.3390/cells10071692 |
Ejemplares similares
-
Molecular Mechanisms Linking Risk Factors to Cholangiocarcinoma Development
por: Ceci, Ludovica, et al.
Publicado: (2022) -
Current Advances in Basic and Translational Research of Cholangiocarcinoma
por: Sato, Keisaku, et al.
Publicado: (2021) -
Mast cells selectively target large cholangiocytes during biliary injury via H2HR‐mediated cAMP/pERK1/2 signaling
por: Zhou, Tianhao, et al.
Publicado: (2022) -
Neuroendocrine Changes in Cholangiocarcinoma Growth
por: Sato, Keisaku, et al.
Publicado: (2020) -
Feedback Signaling between Cholangiopathies, Ductular Reaction, and Non-Alcoholic Fatty Liver Disease
por: Zhou, Tianhao, et al.
Publicado: (2021)